Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome.
暂无分享,去创建一个
[1] N. Mcintyre,et al. Oxford Textbook of Clinical Hepatology , 1999 .
[2] W. Jiménez,et al. Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. , 1998, Human reproduction.
[3] R. Casamitjana,et al. Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators. , 1998, The Journal of clinical endocrinology and metabolism.
[4] W. Jiménez,et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion , 1998, Hepatology.
[5] W. Jelkmann,et al. Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome. , 1998, Human reproduction.
[6] J. Jenkins,et al. The possible role of the immune system in the aetiopathogenesis of ovarian hyperstimulation syndrome. , 1997, Human reproduction.
[7] R. Huhn,et al. Leukocytosis in response to exogenous gonadotrophin stimulation. , 1997, Human reproduction.
[8] J. Schenker,et al. The pathophysiology of ovarian hyperstimulation syndrome--views and ideas. , 1997, Human reproduction.
[9] L. Wildt,et al. O-013. HCG does not directly regulate circulating concentrations of vascular endothelial growth factor in IVF and embryo transfer cycles , 1997 .
[10] V. De Maertelaer,et al. Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation. , 1997, Fertility and sterility.
[11] J. Smitz,et al. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. , 1997, Human reproduction update.
[12] J. Balasch,et al. Increased induced monocyte tissue factor expression by plasma from patients with severe ovarian hyperstimulation syndrome. , 1996, Fertility and sterility.
[13] F. Dhabhar,et al. Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. , 1996, Journal of immunology.
[14] M. Friedlander,et al. Endocrinology: Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-α cannot predict its occurrence , 1996 .
[15] J. Schenker,et al. Endocrinology: Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome , 1996 .
[16] W. Jiménez,et al. Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach , 1996, Acta obstetricia et gynecologica Scandinavica.
[17] M. Friedlander,et al. Elevated Interleukin‐6 Levels in the Ovarian Hyperstimulation Syndrome: Ovarian Immunohistochemical Localization of Interleukin‐6 Signal , 1996, Obstetrics and gynecology.
[18] J. Schölmerich,et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis , 1996, Hepatology.
[19] J. Schenker,et al. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. , 1996, Human reproduction.
[20] M. Friedlander,et al. Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-alpha cannot predict its occurrence. , 1996, Human reproduction.
[21] H. Karube,et al. Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism. , 1995, Fertility and sterility.
[22] T. Gura. Estrogen: key player in heart disease among women , 1995, Science.
[23] W. Jiménez,et al. Immunoreactive endothelin plasma levels in severe ovarian hyperstimulation syndrome. , 1995, Fertility and sterility.
[24] B. Østerud. Cellular interactions in tissue factor expression by blood monocytes , 1995 .
[25] J. Francis,et al. The clinical value of tissue factor assays , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[26] P. August,et al. Role of renin-angiotensin system in blood pressure regulation in pregnancy , 1995, The Lancet.
[27] B. Osterud. Cellular interactions in tissue factor expression by blood monocytes. , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[28] M. Samama,et al. Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports. , 1995, Human reproduction.
[29] K. Inokuchi,et al. Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: mechanism of reactive thrombocytosis. , 1995, Acta haematologica.
[30] B. Brenner,et al. Hypertension: Pathophysiology, Diagnosis, and Management , 1994 .
[31] W. Jiménez,et al. Neurohormonal and Hemodynamic Changes in Severe Cases of the Ovarian Hyperstimulation Syndrome , 1994, Annals of Internal Medicine.
[32] J. Laragh,et al. Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. , 1994, The Journal of clinical endocrinology and metabolism.
[33] D. Herrington,et al. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. , 1994, The American journal of cardiology.
[34] A. Kably Ambe,et al. [The ovarian hyperstimulation syndrome. Institutional experience]. , 1994, Ginecología y Obstetricia de México.
[35] G. Remuzzi,et al. Endothelins in the control of cardiovascular and renal function , 1993, The Lancet.
[36] P. Øian,et al. Enhanced sensitivity of the extrinsic coagulation system during ovarian stimulation for in-vitro fertilization. , 1993, Human reproduction.
[37] T. Masaki,et al. Endothelins: homeostatic and compensatory actions in the circulatory and endocrine systems. , 1993, Endocrine reviews.
[38] B. Battistini,et al. Endothelins: circulating plasma levels and presence in other biologic fluids. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[39] W. Jiménez,et al. Circulating levels of endothelin in cirrhosis. , 1993, Gastroenterology.
[40] D. Webb,et al. The endothelin family of peptides: local hormones with diverse roles in health and disease? , 1993, Clinical science.
[41] Steven D. Carson,et al. The role of tissue factor in the production of thrombin. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[42] N. Laufer,et al. Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment , 1993 .
[43] H. Yarali,et al. The ascites in the ovarian hyperstimulation syndrome does not originate from the ovary. , 1993, Fertility and sterility.
[44] J. Schenker. Prevention and treatment of ovarian hyperstimulation. , 1993, Human reproduction.
[45] K. Badr,et al. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. , 1992, The New England journal of medicine.
[46] J. Rouleau,et al. Elevated Endothelin‐1 in Heart Failure and Loss of Normal Response to Postural Change , 1992, Circulation.
[47] J. Llach,et al. Severe ovarian hyperstimulation syndrome: Role of peripheral vasodilation , 1991, Fertility and sterility.
[48] J. Koziol,et al. Elevated serum interleukin‐6 levels in patients with reactive thrombocytosis , 1991, British journal of haematology.
[49] M. Aboulghar,et al. Modern management of ovarian hyperstimulation syndrome. , 1991, Human reproduction.
[50] M. Pirovino,et al. [Ovarian hyperstimulation syndrome]. , 1991, Schweizerische medizinische Wochenschrift.
[51] O. Tanizawa,et al. Increase in the concentration of immunoreactive endothelin in human pregnancy. , 1991, The Journal of endocrinology.
[52] V. Briner,et al. Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia. , 1991, Obstetrics and gynecology.
[53] J. Slater,et al. The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin , 1991, Clinical endocrinology.
[54] E. Cogan. Atrial natriuretic factor and the endocrine control of electrolyte homeostasis. , 1991, Acta cardiologica.
[55] B. Yuen,et al. The Ovarian Hyperstimulation Syndrome , 1990 .
[56] R. Schrier. Body fluid volume regulation in health and disease: a unifying hypothesis. , 1990, Annals of internal medicine.
[57] B. Brenner,et al. Diverse biological actions of atrial natriuretic peptide. , 1990, Physiological reviews.
[58] J. Llach,et al. Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome. , 1990, Human reproduction.
[59] P. Baylis. 3 Regulation of vasopressin secretion , 1989 .
[60] Muñoz Sj. Pathogenesis of sodium and water retention. , 1989 .
[61] A. Golan,et al. Ovarian hyperstimulation syndrome: an update review. , 1989 .
[62] B. Lunenfeld,et al. Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach. , 1989, Fertility and sterility.
[63] C. Rosenfeld,et al. Local and systemic estradiol-17 beta: effects on uterine and systemic vasodilation. , 1989, The American journal of physiology.
[64] L. Kovács,et al. Regulation of Vasopressin Secretion and Thirst , 1989 .
[65] R. Schrier. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1) , 1988, The New England journal of medicine.
[66] Vicente Arroyo,et al. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.
[67] J. Laragh,et al. Prorenin secretion from human testis: no evidence for secretion of active renin or angiotensinogen. , 1988, The Journal of clinical endocrinology and metabolism.
[68] R. Korthuis,et al. Intestinal capillary filtration in acute and chronic portal hypertension. , 1988, The American journal of physiology.
[69] R. Schrier. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2) , 1988, The New England journal of medicine.
[70] F. Lang. Physiology of diuretic action. , 1988, Renal physiology.
[71] J. Schenker,et al. Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. , 1987, Fertility and sterility.
[72] J. Laragh,et al. Prorenin as a reproductive hormone. New form of the renin system. , 1986, The American journal of medicine.
[73] J. Laragh,et al. Prorenin in high concentrations in human ovarian follicular fluid. , 1986, Science.
[74] D. Karnad,et al. Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. , 1986, British medical journal.
[75] J. Rouleau,et al. Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. , 1986, Kidney international.
[76] J. Laragh,et al. Cyclical secretion of prorenin during the menstrual cycle: synchronization with luteinizing hormone and progesterone. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[77] C. F. Anderson. The Kidney: Physiology and Pathophysiology , 1985 .
[78] F. Trevisani,et al. Renal function impairment induced by change in posture in patients with cirrhosis and ascites. , 1985, Gut.
[79] D M Clive,et al. Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.
[80] Z. Katz,et al. Absence of teratogenicity of indomethacin in ovarian hyperstimulation syndrome. , 1984, International journal of fertility.
[81] J. Gunnells,et al. Plasma Norepinephrine in the Evaluation of Baroreceptor Function in Humans , 1982, Hypertension.
[82] J. Schenker,et al. Ovarian Hyperstimulation Syndrome: A Current Survey , 1978 .
[83] T. Starzl,et al. Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. , 1973, The New England journal of medicine.
[84] J. Coburn,et al. Transplantation of Cadaveric Kidneys from Patients with Hepatorenal Syndrome , 1969 .